Detalhe da pesquisa
1.
Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry.
Catheter Cardiovasc Interv
; 89(1): 37-46, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26947138
2.
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.
Kidney Int
; 90(2): 411-421, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27259368
3.
Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial.
Catheter Cardiovasc Interv
; 80(3): 385-94, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22109997
4.
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
Catheter Cardiovasc Interv
; 77(3): 335-42, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20824769
5.
One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers Study.
Clin Med Insights Cardiol
; 13: 1179546819854059, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285655
6.
Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: The ERACI risk score.
Cardiovasc Revasc Med
; 19(7 Pt A): 792-794, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519729
7.
Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis.
Curr Pharm Des
; 24(4): 465-477, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29308737
8.
Second vs. first-generation drug-eluting stents in complex lesions subsets: 3 years' follow-up of ERACI IV study.
Minerva Cardioangiol
; 65(1): 81-90, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784884
9.
Drug-Eluting vs Bare-Metal Stents for Percutaneous Coronary Intervention.
JAMA Intern Med
; 181(7): 1012-1013, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720301
10.
Randomized trials of PCIs versus CABG surgery: why coronary stenting should remain the first choice of revascularization in non-diabetic patients and why the controversy is still present in diabetics.
Expert Rev Cardiovasc Ther
; 12(3): 297-309, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24490769
11.
Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial).
Am J Cardiol
; 113(5): 815-21, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24528614
12.
Changes in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the ASCERT registry.
World J Cardiol
; 4(8): 242-9, 2012 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22953021
13.
Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial.
J Am Coll Cardiol
; 56(16): 1298-306, 2010 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20691553
14.
New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
J Invasive Cardiol
; 21(8): 378-82, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19652248
15.
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.
EuroIntervention
; 5(2): 255-64, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20449934
16.
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial.
EuroIntervention
; 2(1): 53-60, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19755237
17.
Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study.
J Am Coll Cardiol
; 47(8): 1522-9, 2006 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-16630986